17 Dec 2021 | Discover home page, Discover SigDyn
The cell signalling enzymes PI3Kalpha and PI3Kβ play major roles in the body. Cell signalling Cancer Oncogenic signalling tumour suppressors PI3K/AKT/mTOR Dr Julie Guillermet-Guibert – CRCT team : SigDYN : Integration of cellular signals & PI3K class I, II,...
17 Dec 2021 | Discover home page, Discover SigDyn
The PACMINE project is selected for the Toulouse Cancer Health Foundation’s call for funds The PACMINE project, led by Julie Guillermet-Guibert, Research Officer at the CRCT (Toulouse Cancer Research Centre), and Elisa Boutet-Robinet, Researcher at Toxalim and...
17 Dec 2021 | Discover home page, Discover SigDyn
PI3K proteins sense mechanical forces in tumours. PI3K Cell signalling Cancer Mechanics Mechanotransduction Contact : Julie Guillermet-Guibert – et Mickaël Di-Luoffo – team SigDYN – Integration of cellular signals and PIK class I, II, III. A tumour...
17 Dec 2021 | Dicover R'nBlood, Discover DIAD, Discover home page, Discover ImPact, Discover NetB(IO)², Discover RADOPT, Discover RNAreg, Discover SigDyn, Discover Signather
A look back at the adventure of 17 young secondary school students at the heart of cancer research as part of the Apprentice Researchers scheme deployed for the first time at the CRCT. To be discovered on the dedicated page (in french only) Toulouse Cancer Research...
17 Dec 2021 | Discover home page, Discover SigDyn
Targeted therapies straight to the point or how to counter the defence of cancer cells in response to these therapies? Pancreatic Cancer Targeted Therapy Cellular signalling networks PI3K phosphoproteomics Bioinformatique Transfer research Therapeutic Combination...
28 May 2021 | Discover home page, Discover SigDyn
The rapid progression and poor prognosis of pancreatic cancer: a therapeutic lead. Pancreatic cancer PI3Kalpha Tumour microenvironment Benoit Thibault équipe SigDyn: Signalisation cellulaire intégrée et isoforme de PI3K Pancreatic cancer is a disease with a poor...
